NFL BIOSCIENCES
Biopharmaceutical company that is developing botanical drugs for the treatment of addictions
NFL BIOSCIENCES has raised €3.0M across 1 funding round from 2 investors, most recently a round in Jan 2023. Based in France; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€3.0M
€3,000,000
Funding rounds
1
Investors
2
distinct backers
Active since
2023-01
latest 2023-01
Funding by year
EUR raised per yearNFL BIOSCIENCES — funding by year — interactive chart.
Data table
| NFL BIOSCIENCES — funding by year | |
|---|---|
| 2023 | €3.0M |
Signals
Medium confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Past typical raise window
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-01-31 | Other | €3.0M | Angel Investors,Private Investors | View deal → |
Investors
2Angel InvestorsPrivate Investors
Related news
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData